US Capital Group increased its holdings of Hengrui Pharmaceuticals (01276) by approximately 578,900 shares at a price of about HK$48.07 per share

Zhitongcaijing · 3d ago

The Zhitong Finance App learned that the latest data from the Hong Kong Stock Exchange shows that on September 21, US Capital Group increased its holdings of Hengrui Pharmaceutical (01276) by 578.88.55 million shares, at a price of HK$48.0679 per share, for a total amount of about HK$27.824,300. After the increase in holdings, the latest number of shares held was approximately 288.34 million shares, and the latest shareholding ratio was 11.17%.